Media News
Current News
- New partnership expands infectious disease product range21 April 2008
- Binding Site Board Changes18 March 2008
- Myeloma Today interview with Dr Sundar Jagannath10 March 2008
- Financial results for the year ended 30th September 200718 February 2008
- Binding Site article in FT Money30 January 2008
- Innovative Cancer Marker wins Queen’s Award05 November 2007
- Serum free light chain assay recommended in initial investigation of myeloma19 October 2007
21 April 2008
New partnership expands infectious disease product range
Binding Site have recently signed a distribution agreement with Orgenium Laboratories, Helsinki, Finland, regarding their Infectious Disease tests.
The agreement, which enables Binding Site to sell Orgenium products in a number of countries including UK, France, Germany and Spain, increases their product portfolio for the rapidly growing infectious disease diagnosis market.
The move also facilitates Binding Site's strategy for automation as the Orgenium kits use the same format as Binding Site's range of autoimmune disease and both products can be automated on the same instrument platform.
www.orgenium.com
.jpg)